Filing Details

Accession Number:
0000899243-19-013033
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-10 16:05:18
Reporting Period:
2019-05-08
Accepted Time:
2019-05-10 16:05:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596946 Quotient Ltd QTNT In Vitro & In Vivo Diagnostic Substances (2835) 264719797
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1604628 Jeremy Stackawitz C/O Quotient Limited
28 Esplanade
St Helier Y9 JE2 3QA
President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-05-08 22,500 $8.67 131,939 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Ordinary Shares EmployeeStockOption(right tobuy) $11.92 2026-05-31 20,000 20,000 Direct
Ordinary Shares EmployeeStockOption(right tobuy) $15.17 2025-05-19 22,500 22,500 Direct
Ordinary Shares EmployeeStockOption(right tobuy) $8.00 2024-04-29 60,000 60,000 Direct
Ordinary Shares EmployeeStockOption(right tobuy) $7.58 2027-05-23 40,000 40,000 Direct
Ordinary Shares Multi-yearPerformanceBasedRestrictedStock Unit $0.00 2019-12-31 50,000 50,000 Direct
Ordinary Shares RestrictedStock Units $0.00 30,961 30,961 Direct
Ordinary Shares Restricted Stock Units $0.00 11,175 11,175 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2026-05-31 20,000 20,000 Direct
2025-05-19 22,500 22,500 Direct
2024-04-29 60,000 60,000 Direct
2027-05-23 40,000 40,000 Direct
2019-12-31 50,000 50,000 Direct
30,961 30,961 Direct
11,175 11,175 Direct
Footnotes
  1. 13,334 options have vested and remain exercisable and 6,666 options will vest on June 1, 2019.
  2. All 22,500 options have vested and remain exercisable.
  3. All 60,000 options have vested and remain exercisable.
  4. 13,333 vested on May 24, 2018 and remain exercisable, 13,333 options will vest on May 24, 2019, 13,334 options will vest on May 24, 2020.
  5. Each Multi-year Performance Based Restricted Stock Unit ("MRSU") represents a contingent right to receive one share of Quotient's ordinary shares. The MRSUs vest upon Quotient's ordinary shares achieving a volume weighted average market price of $22.00 per share for 20 consecutive trading days during the period April 1, 2019 to December 31, 2019.
  6. Restricted Stock Units convert into ordinary shares on a one-for-one basis.
  7. On May 24, 2018, the Reporting Person was granted 30,961 Restricted Stock Units, vesting in three equal annual installments beginning May 24, 2019.
  8. On May 23, 2018, the Reporting Person was granted 11,175 restricted stock units that would vest on May 24, 2019 if certain business milestones were achieved on or before December 31, 2018. The business milestones were reached on December 12, 2018, and accordingly the restricted stock units will vest on May 24, 2019.
  9. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2019.
  10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.58 to $8.83, inclusive. The Reporting Person undertakes to provide to Quotient Limited, any security holder of Quotient Limited, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (10) to this Form 4.